ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BHUPENDRA KHATRI MD

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,345Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 54

$4.89M Total Retail Price of All Prescriptions

Rank: 1 out of 54

570 Patients Receiving at Least One Drug in Part D
35%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 570 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 570 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 1,724 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$771 was the average price of a prescription from this provider, compared to $140 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
COPAXONE 455 126 10 1 37
GABAPENTIN 439 168 2 6
BACLOFEN 360 61 3 34
PREDNISONE 244 111 4 2
TIZANIDINE HCL 231 44 5 51
AVONEX 222 46 10 6 69
LYRICA 191 21 7 43
ZOLPIDEM TARTRATE 154 22 8 32
LEVETIRACETAM 148 56 9 21
TOPIRAMATE 130 0 10 27
CARBAMAZEPINE 119 46 11 76
DONEPEZIL HCL 115 65 12 33
AMANTADINE 110 13 13 75
REBIF 97 0 14 109
VESICARE 95 18 15 23
PRIMIDONE 95 39 15 35
GILENYA 89 0 17 114
ALENDRONATE SODIUM 86 14 18 19
PYRIDOSTIGMINE BROMIDE 85 76 19 118
OXYBUTYNIN CHLORIDE 83 25 20 42
HYDROCODONE-ACETAMINOPHEN 77 0 S3 21 5
SERTRALINE HCL 75 0 22 124
CITALOPRAM HBR 72 25 23 62
PROVIGIL 72 15 10 23 128
AMITRIPTYLINE HCL 72 22 R 23 70
RANITIDINE HCL 69 0 26 134
CYMBALTA 65 0 27 64
VENLAFAXINE HCL ER 60 12 28 103
MODAFINIL 58 16 29 149
VIMPAT 52 0 30 162
TAMSULOSIN HCL 52 25 30 11
FLUOXETINE HCL 52 28 30 59
NAMENDA 51 42 33 91
MESTINON 51 49 33 167
NUEDEXTA 51 0 33 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.